Safety of etanercept in elderly subjects with rheumatoid arthritis

OBJECTIVE: To report side effects seen in a clinical cohort of patients aged >65 years with rheumatoid arthritis (RA) treated with the tumor necrosis factor-α TNF-α blocker etanercept and to compare the side effects rate with patients aged ≤65 years. METHODS: All patients with RA that started eta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lurati, Alfredomaria, Marrazza, Mariagrazia, Angela, Katia, Scarpellini, Magda
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819897/
https://www.ncbi.nlm.nih.gov/pubmed/20161980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819897/
https://www.ncbi.nlm.nih.gov/pubmed/20161980

Ejemplares similares